secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001193125-25-321737
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya receives $4.2M milestone from Dr. Reddy's for first ALS patient dosed
--------------------------------------------------------------------------

- Milestone triggered by first patient dosed in ALSTARS trial of COYA 302 for ALS.
- Dosing announced Dec 9, 2025; payment received Dec 16, 2025.
- Payment under Dec 2023 Development and License Agreement with Dr. Reddy's Labs.
- COYA 302 is an investigational therapy targeting amyotrophic lateral sclerosis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312525321737/0001193125-25-321737-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312525321737/d729078d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-321737

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer